Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vincristine-Topotecan-Cyclophosphamide in Non-Metastatic Ewing Sarcoma
NCT01231906Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Nov 2010
- Primary completion
- Mar 2020
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 6
01
Overview
A Phase 3 trial of topotecan liposome in Ewing sarcoma, primitive neuroectodermal tumor (PNET), sponsored by Children's Oncology Group. Started Nov 2010; status: completed.
02
Drugs
topotecan liposome
03
Conditions
Ewing sarcomaprimitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT01231906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231906.